Trials / Completed
CompletedNCT00401752
Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer
A Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, 8 Week Comparative Efficacy and Safety Study of Esomeprazole 20 mg Every Day (qd) Versus Ranitidine 150 mg Twice a Day (Bid) in Patients With an NSAID-associated Gastric Ulcer When Daily NSAID is Continued
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 397 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy of esomeprazole 20 mg dosed once daily and ranitidine 150 mg dosed twice daily through 4 weeks of treatment for the healing of gastric ulcers in patients receiving daily non-steroidal anti-inflammatory drug (NSAID)therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | |
| DRUG | Ranitidine |
Timeline
- Start date
- 2006-03-01
- Completion
- 2008-11-01
- First posted
- 2006-11-22
- Last updated
- 2010-07-08
- Results posted
- 2010-07-08
Locations
9 sites across 2 countries: China, Hong Kong
Source: ClinicalTrials.gov record NCT00401752. Inclusion in this directory is not an endorsement.